Rheumatology

Uzm. Dr. Cansu Akleylek

Doctor and researcher Medipol Esenler Üniversite Hastanesi İstanbul
İngilizce
Open institution page
Suggest a correction

Is this your profile? Claim it and verify your details.

Claim profile

CV

Education and experience

From source

Experience

  • 2023 - 2025Erzurum Şehir Hastanesimedipol.com.tr
  • 2019 - 2022Demiroğlu Bilim Üniversitesi-Florence Nightingale Hastanesimedipol.com.tr
  • 2014 - 2019Trakya Üniversitesi Tıp Fakültesimedipol.com.tr

Education

  • 2022Demiroğlu Bilim Üniversitesi, Romatoloji Bilim Dalımedipol.com.tr
  • 2019Trakya Üniversitesi, Fizik Tedavi ve Rehabilitasyon Anabilim Dalımedipol.com.tr
  • 2014Akdeniz Üniversitesi, Tıp Fakültesimedipol.com.tr

Trust

Where does this information come from?

The source is stated next to each piece of information. If you see something wrong, you can suggest a correction.

  • SpecialtyRheumatologymedipol.com.trFrom source
  • Department name at the sourceRomatoloji(FTR)medipol.com.trFrom source
  • InstitutionMedipol Esenler Üniversite Hastanesimedipol.com.trFrom source
  • Publications37 publicationsOpenAlexFrom source
  • Languagesİngilizcemedipol.com.trFrom source
  • Last synchronised4 November 2026 20:18https://medipol.com.tr/doktorlarimiz/uzmdr-cansu-akleylekmedipol.com.tr

Scientific work

Publications

37 publications

  1. PO:10:272 Long-term outcomes and predictors of treatment response in lupus patients with severe autoimmune hemolytic anemia: results from the Turkish lupus study group

    Lupus Science & Medicine, 2026

    DOI 10.1136/lupus-2026-el.326 Open-access full textSource: OpenAlex

  2. PO:10:251 Long-term treatment outcomes in lupus-associated severe immune thrombocytopenia; data from the Turkish lupus study group

    Lupus Science & Medicine, 2026

    DOI 10.1136/lupus-2026-el.308 Source: OpenAlex

  3. Treatment of hematologic involvement in systemic lupus erythematosus

    Ulusal Romatoloji Dergisi, 2026

    DOI 10.4274/raed.galenos.2026.22932 Source: OpenAlex

  4. The role of shear wave elastography in predicting the development of progressive pulmonary fibrosis in patients with rheumatoid arthritis

    Irish Journal of Medical Science (1971 -), 2025

    DOI 10.1007/s11845-025-04007-1 PMID 40699284 Source: OpenAlex

  5. Latent Tuberculosis Infection in Inflammatory Rheumatic Diseases Before Biological and Synthetic DMARD Treatment: Results from Three Rheumatology Centers in Different Regions of Türkiye

    Thoracic research and practice, 2025

    DOI 10.4274/thoracrespract.2024.24098 PMID 39930694 1 citation (Europe PMC) Open-access full textSource: OpenAlex

  6. COVID-19 vaccination in patients on biologic or targeted-synthetic disease modifying anti-rheumatic drug therapy: A multi center real-world data

    Asian Pacific Journal of Tropical Medicine, 2025

    DOI 10.4103/apjtm.apjtm_253_24 Open-access full textSource: OpenAlex

  7. SERIAL QUANTIFERON-TB TEST SCREENING IN RHEUMATOLOGY PATIENTS DURING TUMOR NECROSIS FACTOR ALPHA INHIBITORS TREATMENT

    Rheumatology Quarterly, 2025

    DOI 10.4274/qrheumatol.galenos.2025.53825 Open-access full textSource: OpenAlex

  8. Venous Thromboembolism May Be Increased in the Early Phases of ANCA ‐Associated Vasculitis and Could Be Associated With a High Body Mass Index: TR ‐ VaS Experience

    International Journal of Rheumatic Diseases, 2025

    DOI 10.1111/1756-185x.70506 PMID 41408677 Source: OpenAlex

  9. Unveiling cancer risk in ANCA-associated vasculitis: result from the Turkish Vasculitis Study Group (TRVaS)

    Internal and Emergency Medicine, 2024

    DOI 10.1007/s11739-024-03577-9 PMID 38553624 5 citations (Europe PMC) Open-access full textSource: OpenAlex

  10. POS0218 VENOUS THROMBOEMBOLISM IN ANCA-ASSOCIATED VASCULITIS MIGHT BE ASSOCIATED WITH DISEASE ACTIVITY: RESULTS OF TR-VaS COHORT

    Annals of the Rheumatic Diseases, 2024

    DOI 10.1136/annrheumdis-2024-eular.2661 Source: OpenAlex

View all 37 publications